James B. Harris

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators

James B. Harris, Miles Weinberger, Edward G. Nassif et al. · The Journal of Pediatrics · 1987 · 127 citations

Asthma, Short Courses, Allergy +6

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 84 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma

Richard C. Ahrens, James B. Harris, Gary Milavetz et al. · Journal of Allergy and Clinical Immunology · 1987 · 64 citations · Full text

Asthma, Allergy, Allergy Medicine +7

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta et al. · The Journal of Pediatrics · 2015 · 59 citations

Advanced Lung Disease, Forced Expiratory Volume, Pulmonary Physiology +6